INZY Cash from Financing Activities - Cash Flow Statement - Inozyme Pharma, Inc. - IntrinsicAlpha

Inozyme Pharma, Inc. INZY

Healthcare - Biotechnology - NASDAQ - US

$ 3.99

0.251 %

$ 258 M

Market Cap

-2.37

P/E

INZY - CASH FROM FINANCING ACTIVITIES

Cash from Financing Activities INZY - Inozyme Pharma, Inc.

11.4 M

LAST VALUE

-60.43%

2 YEAR CAGR

-13.08%

5 YEAR CAGR

0.00%

10 YEAR CAGR